Steek is an AI-powered competitive intelligence platform that lets you research any market, competitor, or trend in 30 seconds. It monitors 40+ premium sources and generates deep analysis with competitive landscapes, key findings, action items, and foresight reports â€” all with citations.

Pick any market signal, trend, or topic. Steek instantly generates a deep competitive research report including executive summary, key findings, competitive landscape analysis, action items, and risk assessment â€” drawing from 40+ premium sources with full citations.

Steek is built for product managers, strategists, researchers, and decision-makers who need fast, reliable competitive intelligence. If you spend hours researching markets, competitors, or trends â€” Steek does it in 30 seconds.

What types of research can Steek generate?

Steek generates five types of intelligence: Quick Insights (instant signal analysis), Deep Research (comprehensive reports with competitive landscape), Foresight Reports (trend predictions and strategic forecasting), Visual Maps (interactive concept diagrams), and Video Intelligence (key takeaways from video content).

Is Steek free to use?

Yes, Steek offers a free tier with generous quotas for all features including competitive research, quick insights, foresight analysis, visual maps, and shareable report links. Premium plans unlock higher quotas and advanced features.

How fast is Steek compared to manual research?

Steek generates a full competitive research report â€” with executive summary, key findings, competitive landscape, action items, and citations â€” in about 30 seconds. The same analysis would typically take a human analyst 3-5 hours.

Steek

Smart Intelligence Tracking

Dashboard

Signal #150063NEGATIVE

Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult

A clinical trial failure and U.S. competition have been tough for the Danish pharmaceutical firm. CFO Karsten Munk Knudsen says the company is doubling down on innovation and its weight loss pills as it looks toward its next stage of growth.

Fortune AIabout 12 hours ago

Read Full Article

Explore with AI-Powered Tools

View All Signals

Explore more AI intelligence

Want to discover more AI signals like this?

Explore Steek

Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult | Steek AI Signal | Steek

Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult

Explore with AI-Powered Tools

Quick Insights

Deep Research

Visual Map

Foresight

Learn

View All Signals